Patents Assigned to Impact Biomedicines, Inc.
  • Methods of treating myeloproliferative disorders
    Patent number: 11400092
    Abstract: The present disclosure provides methods of mitigating thiamine deficiency.
    Type: Grant
    Filed: December 23, 2021
    Date of Patent: August 2, 2022
    Assignee: Impact Biomedicines, Inc.
    Inventors: Tymara Berry, John Hood, Catriona Jamieson, Curtis L. Scribner
  • Compositions and methods for treating myelofibrosis
    Patent number: 10391094
    Abstract: Provided herein are compositions and methods for treating myelofibrosis in a subject. The methods comprise administering to the subject an effective amount of compound which is which is N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino]benzenesulfonamide or a pharmaceutical salt thereof or a hydrate thereof.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: August 27, 2019
    Assignee: Impact Biomedicines, Inc.
    Inventors: Arvind Jayan, Janice Cacace